查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1870971

凝膠柱凝集試驗系統市場（依測試類型、最終用戶、產品類型、應用、檢體類型和血型鑑定系統分類）－全球預測，2025-2032年

Gel Column Agglutination Test system Market by Test Type, End User, Product Type, Application, Sample Type, Blood Group System - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，凝膠柱凝集試驗系統市場規模將達到 58.9 億美元，複合年成長率為 6.73%。

主要市場統計數據
基準年 2024 35億美元
預計年份：2025年 37.3億美元
預測年份：2032年 58.9億美元
複合年成長率 (%) 6.73%

全面介紹凝膠柱凝集系統，說明在免疫血液學中的臨床優勢、工作流程整合和品質要求。

凝膠柱凝集試驗系統憑藉其可重複性高、主觀性低且易於自動化等優點，已從實驗室的探索性技術發展成為免疫血液學和輸血醫學的核心技術。本次報告將概述該技術的臨床目標、操作優勢以及與血庫、診斷實驗室、醫院和研究機構的重要合作。我們將闡述基於凝膠的方法如何簡化輸血前檢測、抗體檢測和表現型分析的工作流程，同時減少人工操作和變異性，這在高通量、安全至關重要的環境中尤其重要。

自動化、試劑進步和監管重點正在重塑免疫血液學和輸血服務的工作流程和採購重點。

自動化、試劑創新和不斷發展的臨床工作流程正在改變凝膠柱凝集系統的模式。自動化和半自動化系統的進步降低了操作者差異並提高了通量，而改進的試劑卡和增強的凝膠基質則提高了分析靈敏度和穩定性。因此，實驗室能夠提供更一致的抗體篩檢和鑑定結果，從​​而促進更安全的輸血操作和可靠的血清學監測。

2025年關稅調整對診斷耗材和自動化免疫血液學系統的籌資策略和供應鏈韌性的影響

2025年美國關稅調整為凝膠柱凝集試驗系統及其耗材的採購和供應鏈管理帶來了新的考量。不斷變化的關稅環境迫使採購部門重新評估其籌資策略，更嚴格地審查供應商多元化、到岸成本計算和庫存緩衝。為此，多個相關人員正與供應商密切合作，協商長期供應協議和緊急計畫，以降低關稅波動帶來的風險。

深入洞察檢測類型多樣性、最終用戶需求、產品差異、應用需求、檢體處理和血型鑑定等複雜因素。

細分市場分析揭示了凝膠柱凝集試驗系統在臨床應用和採購模式上的多樣性。按試驗類型分類，市場涵蓋： -抗體篩檢（3細胞和2細胞組合試驗）-電子和人工交叉配對試驗交叉配對試驗交叉配對試驗-正向和反向血型鑑定-鑑定試驗，包括組合鑑別和擴展表現型分析。這些試驗類型的差異會影響試劑配方、儀器相容性和檢驗管道，從而指導實驗室決定是優先選擇多功能平台還是專用試劑盒。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 臨床實驗室擴大採用高通量自動化凝膠柱系統，加快了血液相容性檢測的速度。
  • 透過整合雲端基礎的實驗室資訊管理系統和凝膠柱工作流程，增強數據可追溯性
  • 開發用於分散式醫療環境中照護現場血型鑑定的微流體凝膠卡平台
  • 引入人工智慧驅動的光學讀數儀進行凝膠柱凝集試驗，可減少人工判讀錯誤
  • 擴展多重凝膠柱檢測技術，以同時檢測多種血型抗原和抗體
  • 診斷設備製造商與生技公司建立策略聯盟，推動凝膠柱聚集技術創新
  • 監管協調努力正在塑造新興經濟體先進凝膠柱測試設備的市場進入

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依測試類型分類的凝膠柱凝集試驗系統市場

  • 抗體篩檢
    • 三板
    • 雙電池板
  • 橫斷面研究
    • 電子交叉測試
    • 手動交叉測試
  • 血型測定
    • 前向分組
    • 反向分組
  • 鑑別
    • 擴展表現型分析
    • 面板識別

9. 依最終使用者分類的凝膠柱凝集試驗系統市場

  • 血庫
    • 私人血庫
    • 公共血庫
  • 診斷實驗室
    • 醫院檢查室
    • 參考測試室
  • 醫院
    • 二級護理
    • 三級醫療
  • 研究所
    • 學術機構
    • 製藥公司

第10章 凝膠柱凝集試驗系統市場（依產品類型分類）

  • 消耗品
    • 凝膠柱
    • 試劑卡
  • 裝置
    • 自動化系統
    • 半自動系統

第11章 凝膠柱凝集試驗系統市場（依應用領域分類）

  • 輸血
    • 免疫血液學
    • 輸血前檢測
  • 疾病診斷
    • 自體免疫疾病
    • 感染疾病標記物
  • 研究
    • 學術研究
    • 臨床試驗

12. 依檢體類型分類的凝膠柱凝集試驗系統市場

  • 電漿
    • 冷凍血漿
    • 新鮮冷凍血漿
  • 紅血球
    • 濃縮紅血球
    • 洗滌過的紅血球
  • 全血
    • 枸櫞酸血
    • EDTA 血

13. 依血型鑑定系統分類的凝膠柱凝集試驗系統市場

  • ABO
    • A
    • AB
    • B
    • O
  • Duffy
  • Kell
    • K1
    • K2
  • Kidd
  • MNS
  • Rh
    • C
    • c
    • D
    • E
    • e

14. 各地區凝膠柱凝集試驗系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 凝膠柱凝集試驗系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國凝膠柱凝集試驗系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Ortho Clinical Diagnostics Holdings plc
    • Bio-Rad Laboratories, Inc.
    • Grifols, SA
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Abbott Laboratories
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Immucor, Inc.
    • Diagast
    • Abacus Diagnostica Ltd.
Product Code: MRR-1A1A064C0523

The Gel Column Agglutination Test system Market is projected to grow by USD 5.89 billion at a CAGR of 6.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.50 billion
Estimated Year [2025] USD 3.73 billion
Forecast Year [2032] USD 5.89 billion
CAGR (%) 6.73%

Comprehensive orientation to gel column agglutination systems that explains clinical advantages, workflow integration, and quality imperatives for immunohematology

The gel column agglutination test system has grown from a laboratory curiosity into a core technology for immunohematology and transfusion medicine, driven by its reproducibility, reduced subjectivity, and compatibility with automation. This introduction frames the technology's clinical purpose, operational advantages, and the critical interfaces with blood banks, diagnostic laboratories, hospitals, and research institutes. It explains how gel-based methodologies streamline pretransfusion testing, antibody detection, and phenotyping workflows while reducing manual handling and variability, which is particularly consequential in high-throughput and safety-critical environments.

In practice, the system's modularity supports both high-volume automated platforms and compact semi-automated or manual formats, making it relevant across diverse institutional settings. The technology's consumable and instrument components interplay to deliver standardized reactions, and the system's tolerance for different sample types enhances its applicability. This introduction also contextualizes quality management considerations, such as traceability, lot-to-lot reagent consistency, and internal controls, which determine clinical confidence. Finally, it highlights how ongoing innovation in reagents, column matrices, and instrument software continues to expand diagnostic capabilities and laboratory efficiency, setting the stage for deeper exploration throughout this summary.

How automation, reagent advancements, and regulatory emphasis are reshaping workflows and procurement priorities across immunohematology and transfusion services

The landscape for gel column agglutination systems is experiencing transformative shifts shaped by automation, reagent innovation, and evolving clinical workflows. Advances in automated and semi-automated systems have reduced operator-dependent variability and increased throughput, while reagent card refinements and gel matrix enhancements have improved analytical sensitivity and stability. As a result, laboratories can deliver more consistent antibody screening and identification outcomes, facilitating safer transfusion practices and more reliable serological research.

Concurrent shifts in clinical practice, such as expanded pretransfusion testing protocols and heightened immunohematology complexity due to diverse patient populations, drive demand for more capable testing platforms. Regulatory emphasis on traceability and validation has pushed vendors to integrate better software controls, audit trails, and user authentication, thereby aligning laboratory practices with compliance requirements. Furthermore, integration with laboratory information systems and digital reporting tools is accelerating, enabling smoother data flow from blood banks and diagnostic labs to hospital information systems. These combined trends are reshaping procurement priorities and operational models across institutional settings.

Impacts of 2025 tariff adjustments on procurement strategies and supply chain resiliency for diagnostic consumables and automated immunohematology systems

United States tariff changes in 2025 introduced additional considerations for procurement and supply chain management of gel column agglutination test systems and their consumables. The tariff environment has prompted procurement teams to re-evaluate sourcing strategies, with increased scrutiny on supplier diversification, landed cost calculations, and inventory buffering. In response, several stakeholders have pursued closer collaboration with suppliers to negotiate long-term supply agreements and contingency arrangements that mitigate exposure to customs and tariff volatility.

Operational teams have adjusted purchasing cadences and validation schedules to accommodate longer lead times for critical consumables such as reagent cards and gel columns. Concurrently, manufacturers and distributors have explored alternative manufacturing footprints, nearshoring strategies, and tariff classification reviews to optimize cost structures. For end users, the primary impact has been a renewed emphasis on supply chain resilience, with institutions prioritizing validated secondary suppliers and enhanced stock management. Overall, the tariff developments of 2025 accelerated a strategic pivot toward supply chain robustness and closer vendor partnerships across the diagnostic ecosystem.

Deep segmentation-driven insights that reconcile test-type diversity, end-user requirements, product variation, application demands, sample handling, and blood group complexity

Segmentation analysis reveals the diversity of clinical use cases and procurement patterns that define gel column agglutination test system adoption. Based on Test Type, the market covers Antibody Screening with both Three-Cell Panel and Two-Cell Panel approaches, Crossmatch performed via Electronic Crossmatch and Manual Crossmatch methods, Grouping split between Forward Grouping and Reverse Grouping techniques, and Identification that includes Extended Phenotyping alongside Panel Identification. These test-type distinctions influence reagent formulation, instrument compatibility, and validation pathways, and they guide laboratory decisions on whether to prioritize versatile platforms or specialized kits.

Based on End User, the technology serves Blood Banks, Diagnostic Laboratories, Hospitals, and Research Institutes, with Blood Banks further differentiated into Private Blood Banks and Public Blood Banks, Diagnostic Laboratories encompassing Hospital Laboratories and Reference Laboratories, Hospitals spanning Secondary Care and Tertiary Care facilities, and Research Institutes including Academic Institutes and Pharmaceutical Companies. The diverse end-user landscape results in varied purchasing cycles, service expectations, and capital allocation considerations, with blood banks often favoring reliability and throughput while research entities emphasize flexibility and assay customization.

Based on Product Type, the offerings include Consumables such as Gel Columns and Reagent Cards alongside Instruments categorized as Automated Systems and Semi-Automated Systems. Consumable lifecycle, lot management, and compatibility with existing instruments drive repeat purchasing behavior, whereas instrument selection reflects anticipated testing volumes, laboratory staffing, and integration requirements. Based on Application, the primary use areas include Blood Transfusion oriented work such as Immunohematology and Pretransfusion Testing, Disease Diagnostics focused on Autoimmune Disorders and Infectious Disease Markers, and Research applications spanning Academic Research and Clinical Trials. Each application sets distinct performance and documentation expectations that shape product development and validation strategies.

Based on Sample Type, the systems accept Plasma types including Cryoprecipitate and Fresh Frozen Plasma, Red Cells such as Packed Red Cells and Washed Red Cells, and Whole Blood in formats like Citrated Blood and EDTA Blood, each carrying unique preanalytical handling and stability implications. Finally, based on Blood Group System, testing addresses ABO categories subdivided into A, AB, B, and O, Duffy, Kell with distinctions such as K1 and K2, Kidd, MNS, and Rh with subtypes including C, c, D, E, and e. Collectively, these segmentation perspectives highlight the need for flexible, validated solutions that accommodate test complexity, varied sample matrices, and diverse institutional requirements.

Regional adoption patterns highlighting how healthcare infrastructure, regulatory environments, and distribution networks drive procurement and operational priorities globally

Regional dynamics shape adoption patterns, procurement priorities, and regulatory interactions for gel column agglutination systems, creating distinct operational landscapes across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established blood services and integrated hospital systems often emphasize standardization, high-throughput automation, and interoperability with laboratory IT systems, while procurement teams focus on long-term supplier relationships and service coverage to support national transfusion networks.

Across Europe, Middle East & Africa, regulatory harmonization in parts of Europe promotes stringent validation and documentation practices, whereas countries in the Middle East and Africa present heterogeneous healthcare infrastructures that demand adaptable products and robust field support. Consequently, multi-tier product strategies that include compact semi-automated systems and resilient consumables find traction across these regions. Moving to Asia-Pacific, rapid expansion of diagnostic capacity, growing emphasis on pretransfusion safety, and diverse healthcare delivery models create strong demand for both scalable automated platforms and cost-effective reagent solutions. In all regions, distribution models, local regulatory requirements, and training capabilities influence the speed and scale of adoption, while regional health priorities and funding mechanisms continue to determine which applications receive prioritized investment.

Competitive landscape analysis illustrating how product differentiation, service models, and strategic partnerships determine long-term supplier selection and customer retention

Competitive dynamics in the gel column agglutination space reflect a balance between established diagnostic players, specialized reagent manufacturers, and emerging automation-focused entrants. Leading instrument providers compete on ease of integration, software robustness, and service networks, while consumable manufacturers differentiate through reagent stability, sensitivity, and lot consistency. Strategic partnerships between reagent specialists and instrument OEMs are increasingly common, aligning product roadmaps with laboratory needs for validated, end-to-end solutions.

In addition, some companies pursue modular portfolios that support both high-volume automated laboratories and lower-volume settings, thereby widening addressable end-user segments. Others emphasize value-added services such as on-site validation support, customized training programs, and rapid replacement logistics to strengthen customer loyalty. Investment in R&D continues to center on reagent chemistry, gel matrix optimization, and digital reporting features that facilitate interpretation and regulatory compliance. Collectively, these competitive approaches shape procurement conversations and influence which suppliers are selected for long-term partnerships.

Actionable guidance for leaders to reinforce supply chains, innovate reagent and instrument capabilities, and elevate customer engagement to secure competitive advantage

Industry leaders should prioritize a combination of strategic supply chain actions, product development focus, and customer engagement practices to maintain advantage in a changing environment. First, strengthening supplier diversification and inventory orchestration will mitigate exposure to tariff volatility and shipping disruptions, while near-term contractual agreements with multiple validated suppliers will preserve operational continuity. Second, accelerating development of reagent robustness, extended shelf-life formulations, and gel matrix enhancements will address laboratory demands for reduced waste and more predictable performance.

Simultaneously, companies should invest in instrument interoperability, intuitive software, and secure data exchange capabilities to meet hospital and laboratory expectations for integration and compliance. Enhancing service models through remote diagnostics, virtual training, and outcome-focused validation packages will deepen customer relationships and reduce downtime. For procurement decision-makers, establishing cross-functional evaluation teams that include clinical scientists, laboratory managers, and IT leads will ensure that purchases align with workflow realities and regulatory responsibilities. Finally, proactive engagement with regional distributors and regulatory bodies will expedite market entry and sustain adoption across varied healthcare environments.

Methodological overview describing stakeholder engagement, technical literature synthesis, and triangulation approaches used to produce operationally relevant insights

This research synthesizes primary interviews, targeted vendor briefings, and a rigorous review of technical and regulatory literature to assemble actionable insights on gel column agglutination systems. Stakeholder inputs included clinical laboratory directors, transfusion service physicians, procurement specialists, and validation scientists, which informed interpretations of workflow challenges, product performance, and service expectations. Vendor consultations provided visibility into instrument roadmaps, consumable innovations, and distribution strategies, while technical literature helped clarify performance characteristics of gel matrices and reagent chemistries.

Evidence was triangulated across multiple sources to ensure internal consistency and to surface practical implications for end users. Where appropriate, methodology emphasized reproducibility by cross-checking claims against clinical practice guidelines, device manuals, and peer-reviewed findings on serological performance. The approach prioritized operational relevance, focusing on aspects such as ease of integration, validation burden, reagent handling, and training requirements that directly influence adoption. Limitations related to proprietary performance data and rapidly evolving product features were mitigated through follow-up vendor validation and targeted expert review to ensure conclusions remain robust and actionable.

Synthesis of core findings that link technological strengths, operational priorities, and strategic supplier engagement to enhance transfusion safety and diagnostic workflows

In conclusion, gel column agglutination systems represent a mature yet evolving technology that continues to address core challenges in immunohematology by improving reproducibility, reducing subjectivity, and supporting automation. The interplay between consumables and instruments determines clinical utility, and the need for validated, interoperable solutions grows as laboratories scale testing volumes and integrate with broader hospital IT ecosystems. Recent supply chain pressures and regulatory emphasis have further elevated the importance of supplier reliability and product documentation, requiring both vendors and end users to adapt procurement and operational practices.

Looking ahead, incremental innovations in reagent chemistry, gel formulations, and software integration will continue to shape laboratory workflows and influence adoption across blood banks, diagnostic laboratories, hospitals, and research institutes. For decision-makers, the priority is to align technology selection with clinical workflows, validation capacity, and regional regulatory expectations, while maintaining supply chain resilience. When these elements are coordinated, organizations can enhance transfusion safety, streamline diagnostic processes, and ensure that investments yield measurable operational improvements.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of high-throughput automated gel column systems in clinical laboratories to accelerate blood compatibility testing
  • 5.2. Integration of cloud-based laboratory information management systems with gel column workflows for enhanced data traceability
  • 5.3. Development of microfluidic gel card platforms enabling point-of-care blood grouping diagnostics in decentralized healthcare settings
  • 5.4. Implementation of AI-driven optical readers for gel column agglutination assays to reduce manual interpretation errors
  • 5.5. Expansion of multiplexed gel column tests for simultaneous detection of multiple blood group antigens and antibodies
  • 5.6. Strategic collaborations between diagnostic firms and biotech companies driving innovation in gel column agglutination technologies
  • 5.7. Regulatory harmonization efforts shaping market access for advanced gel column testing devices across emerging economies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gel Column Agglutination Test system Market, by Test Type

  • 8.1. Antibody Screening
    • 8.1.1. Three-Cell Panel
    • 8.1.2. Two-Cell Panel
  • 8.2. Crossmatch
    • 8.2.1. Electronic Crossmatch
    • 8.2.2. Manual Crossmatch
  • 8.3. Grouping
    • 8.3.1. Forward Grouping
    • 8.3.2. Reverse Grouping
  • 8.4. Identification
    • 8.4.1. Extended Phenotyping
    • 8.4.2. Panel Identification

9. Gel Column Agglutination Test system Market, by End User

  • 9.1. Blood Banks
    • 9.1.1. Private Blood Banks
    • 9.1.2. Public Blood Banks
  • 9.2. Diagnostic Laboratories
    • 9.2.1. Hospital Laboratories
    • 9.2.2. Reference Laboratories
  • 9.3. Hospitals
    • 9.3.1. Secondary Care
    • 9.3.2. Tertiary Care
  • 9.4. Research Institutes
    • 9.4.1. Academic Institutes
    • 9.4.2. Pharmaceutical Companies

10. Gel Column Agglutination Test system Market, by Product Type

  • 10.1. Consumables
    • 10.1.1. Gel Columns
    • 10.1.2. Reagent Cards
  • 10.2. Instruments
    • 10.2.1. Automated Systems
    • 10.2.2. Semi-Automated Systems

11. Gel Column Agglutination Test system Market, by Application

  • 11.1. Blood Transfusion
    • 11.1.1. Immunohematology
    • 11.1.2. Pretransfusion Testing
  • 11.2. Disease Diagnostics
    • 11.2.1. Autoimmune Disorders
    • 11.2.2. Infectious Disease Markers
  • 11.3. Research
    • 11.3.1. Academic Research
    • 11.3.2. Clinical Trials

12. Gel Column Agglutination Test system Market, by Sample Type

  • 12.1. Plasma
    • 12.1.1. Cryoprecipitate
    • 12.1.2. Fresh Frozen Plasma
  • 12.2. Red Cells
    • 12.2.1. Packed Red Cells
    • 12.2.2. Washed Red Cells
  • 12.3. Whole Blood
    • 12.3.1. Citrated Blood
    • 12.3.2. EDTA Blood

13. Gel Column Agglutination Test system Market, by Blood Group System

  • 13.1. ABO
    • 13.1.1. A
    • 13.1.2. AB
    • 13.1.3. B
    • 13.1.4. O
  • 13.2. Duffy
  • 13.3. Kell
    • 13.3.1. K1
    • 13.3.2. K2
  • 13.4. Kidd
  • 13.5. MNS
  • 13.6. Rh
    • 13.6.1. C
    • 13.6.2. c
    • 13.6.3. D
    • 13.6.4. E
    • 13.6.5. e

14. Gel Column Agglutination Test system Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Gel Column Agglutination Test system Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Gel Column Agglutination Test system Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Ortho Clinical Diagnostics Holdings plc
    • 17.3.2. Bio-Rad Laboratories, Inc.
    • 17.3.3. Grifols, S.A.
    • 17.3.4. Thermo Fisher Scientific Inc.
    • 17.3.5. Danaher Corporation
    • 17.3.6. Abbott Laboratories
    • 17.3.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.8. Immucor, Inc.
    • 17.3.9. Diagast
    • 17.3.10. Abacus Diagnostica Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL GEL COLUMN AGGLUT